Mounjaro: What You Should Know About the New Type 2 Diabetes Medicine
Come May 13th, 2022 a new medicine for Type 2 Diabetes known as Mounjaro (Tirzepatide) became available in the market. It is a first-of-its-class…
This study is looking at having patients with Type 2 Diabetes wear a Medtronic insulin pump instead of giving multiple daily insulin shots or using their current pump. A glucose sensor will be worn with the pump to continuously monitor glucose levels. The pump combined with the continuous glucose sensor could help patients closely monitor blood sugars and have better control over their diabetes.
If you qualify, you will receive study-related care and insulin pump/supplies at no cost. You will also receive compensation for travel expenses.
To take part in the study, participants should be:
See if you qualify
CEO and Medical Director
Sub-Investigator
Sub-Investigator
CRC Manager
Clinical Research Coordinator
Clinical Research Coordinator
Clinical Research Coordinator
Clinical Research Coordinator
Clinical Research Coordinator
Have questions? Call us at (515) 329-6800 or email us at info@iowadiabetes.com.